Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 31 Pancreatic Neoplasms 8 Colorectal Neoplasms 7 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Breast Neoplasms 3 Recurrence 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Gastric Cancer 2 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Liver Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1 Advanced Biliary Tract Cancer 1

Interventions

Cisplatin 252 Radiotherapy 176 Cetuximab 144 pembrolizumab 120 Docetaxel 96 Fluorouracil 92 Carboplatin 80 Paclitaxel 77 Radiotherapy, Intensity-Modulated 69 Nivolumab 37 Radiation 30 Drug Therapy 30 Erlotinib Hydrochloride 26 Gemcitabine 25 Gefitinib 21 Cyclophosphamide 21 Surveys and Questionnaires 20 Surgical Procedures, Operative 19 Standard of Care 19 Pemetrexed 19 durvalumab 18 Magnetic Resonance Spectroscopy 17 Capecitabine 17 Radiosurgery 16 Celecoxib 16 atezolizumab 15 Filgrastim 15 Amifostine 15 Low-Level Light Therapy 14 Everolimus 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × titanium silicide × Clear all

NCT01645748 2012-07-20

TPSHNSCC

Chonnam National University Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡